International Biotechnology Trust as of Sept. 30, 2018
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 51 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Beigene (BGNE) | 8.3 | $17M | 254k | 68.63 | |
| G1 Therapeutics (GTHX) | 6.9 | $15M | 52k | 281.43 | |
| Gilead Sciences (GILD) | 5.0 | $11M | 200k | 52.96 | |
| Seattle Genetics | 4.8 | $10M | 68k | 147.80 | |
| Array BioPharma | 4.7 | $9.8M | 845k | 11.66 | |
| Molecular Templates | 4.6 | $9.7M | 31k | 309.83 | |
| Celgene Corporation | 4.5 | $9.6M | 705k | 13.59 | |
| Alnylam Pharmaceuticals (ALNY) | 4.1 | $8.7M | 82k | 106.56 | |
| Rigel Pharmaceuticals (RIGL) | 3.5 | $7.5M | 586k | 12.73 | |
| Incyte Corporation (INCY) | 3.5 | $7.4M | 35k | 210.37 | |
| Avexis | 3.4 | $7.2M | 97k | 74.36 | |
| Fibrogen (FGEN) | 2.8 | $6.0M | 429k | 13.93 | |
| Agios Pharmaceuticals (AGIO) | 2.8 | $5.9M | 125k | 47.20 | |
| Aerie Pharmaceuticals | 2.7 | $5.7M | 370k | 15.33 | |
| Horizon Pharma | 2.6 | $5.5M | 322k | 16.96 | |
| Deciphera Pharmaceuticals (DCPH) | 2.5 | $5.3M | 90k | 59.21 | |
| Ligand Pharmaceuticals In (LGND) | 2.4 | $5.1M | 144k | 35.16 | |
| ACADIA Pharmaceuticals (ACAD) | 2.2 | $4.6M | 13k | 344.92 | |
| Shire | 2.0 | $4.2M | 110k | 38.04 | |
| Regeneron Pharmaceuticals (REGN) | 1.8 | $3.9M | 300k | 12.88 | |
| Amicus Therapeutics (FOLD) | 1.7 | $3.5M | 53k | 67.10 | |
| Puma Biotechnology (PBYI) | 1.6 | $3.5M | 25k | 139.00 | |
| Jazz Pharmaceuticals (JAZZ) | 1.6 | $3.3M | 36k | 94.31 | |
| Penumbra (PEN) | 1.6 | $3.3M | 27k | 123.85 | |
| Cymabay Therapeutics | 1.4 | $2.9M | 72k | 40.06 | |
| Halozyme Therapeutics (HALO) | 1.3 | $2.8M | 22k | 128.94 | |
| Portola Pharmaceuticals | 1.2 | $2.5M | 43k | 59.13 | |
| Globus Med Inc cl a (GMED) | 1.2 | $2.5M | 112k | 22.04 | |
| Bluebird Bio (BLUE) | 1.1 | $2.3M | 77k | 29.69 | |
| Alexion Pharmaceuticals | 1.0 | $2.2M | 37k | 59.15 | |
| Gw Pharmaceuticals Plc ads | 1.0 | $2.0M | 52k | 39.55 | |
| Axogen (AXGN) | 0.9 | $1.9M | 17k | 111.94 | |
| Optinose (OPTN) | 0.8 | $1.7M | 16k | 108.28 | |
| Sangamo Biosciences (SGMO) | 0.8 | $1.7M | 147k | 11.50 | |
| Intersect Ent | 0.8 | $1.6M | 10k | 164.10 | |
| Clovis Oncology | 0.7 | $1.5M | 31k | 46.62 | |
| Paratek Pharmaceuticals | 0.7 | $1.5M | 113k | 12.96 | |
| Exelixis (EXEL) | 0.6 | $1.3M | 9.6k | 132.50 | |
| Esperion Therapeutics (ESPR) | 0.6 | $1.3M | 29k | 43.52 | |
| BioMarin Pharmaceutical (BMRN) | 0.6 | $1.2M | 145k | 8.49 | |
| Ionis Pharmaceuticals (IONS) | 0.5 | $1.1M | 75k | 15.13 | |
| Adamas Pharmaceuticals | 0.5 | $1.0M | 65k | 15.92 | |
| Foamix Pharmaceuticals | 0.5 | $1.0M | 69k | 15.01 | |
| Sage Therapeutics (SAGE) | 0.4 | $809k | 21k | 38.61 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $766k | 104k | 7.40 | |
| Biogen Idec (BIIB) | 0.3 | $710k | 108k | 6.57 | |
| Enteromedics | 0.3 | $673k | 73k | 9.22 | |
| Anaptysbio Inc Common (ANAB) | 0.3 | $543k | 59k | 9.27 | |
| Radius Health | 0.2 | $502k | 12k | 41.83 | |
| Merus N V (MRUS) | 0.1 | $257k | 19k | 13.67 | |
| Neurocrine Biosciences (NBIX) | 0.0 | $2.1k | 53k | 0.04 |
